Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00732212 · ClinicalTrials.gov registry record · NA
Doppler Ultrasound Probe for Blood Flow Detection in Severe Upper Gastrointestinal Hemorrhage
A NA study of Endoscopy and UGI Bleeding, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 235
- Enrollment target
- 2
- Study locations
NCT00732212: Completed NA study of Endoscopy and UGI Bleeding, sponsored by VA Office of Research and Development.
NCT00732212 is a NA study of Endoscopy and UGI Bleeding that has completed, run by VA Office of Research and Development. The registered enrollment target is 235 participants, above the 213-participant average among 7 other Endoscopy trials with a reported enrollment target (10% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00732212, a NA study of Endoscopy and UGI Bleeding, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 235 participants
- Enrollment target
- 2
- Study locations
Study Summary
The main purposes of this study are to compare clinical outcomes of two groups of patients with similar medical conditions (one with non-variceal upper gastrointestinal (UGI) lesions such as ulcers and another group with varices or portal hypertensive lesions) who are treated either with current standard visually guided endoscopic treatment according to stigmata of hemorrhage or with endoscopic Doppler endoscopic ultrasound probe (DEP) monitoring of blood flow in the lesion.
Primary Outcome
The primary outcome is index lesion rebleeding rate up to 30 days in 2 subgroups- non-variceal or variceal-portal hypertension lesions according to standard visually guided hemostasis vs. Doppler assisted.
Conditions Studied
Interventions
- DEVICE Doppler endoscopic ultrasound probe for blood flow detection
- OTHER Standard endoscopic hemostasis
Study Locations (2)
California
- Ronald Reagan UCLA Medical Center - Los Angeles
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2009-02-18 |
| Est. Completion | 2016-01-07 |
| Phase | NA |
What the finished NCT00732212 record still lists
NCT00732212 is an interventional study that assigns participants to a tested intervention. The registered 235 participants enrollment target is mid-sized for trials with a published cap, above the 213-participant average among 7 other Endoscopy trials with a reported enrollment target (10% higher).
The record links to 5 conditions, with Endoscopy appearing as the primary indexed condition, and to 2 interventions - of which Doppler endoscopic ultrasound probe for blood flow detection is the first listed.
NCT00732212 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00732212 about?
NCT00732212 is a clinical study titled "Doppler Ultrasound Probe for Blood Flow Detection in Severe Upper Gastrointestinal Hemorrhage". The main purposes of this study are to compare clinical outcomes of two groups of patients with similar medical conditions (one with non-variceal upper gastrointestinal (UGI) lesions such as ulcers and another group with varices or portal hypertensive lesions) who are treated either with current sta...
What is the current status of trial NCT00732212?
This trial is currently completed. It is a NA study. The enrollment target is 235 participants. The study started on 2009-02-18. Estimated completion is 2016-01-07.
What conditions does trial NCT00732212 study?
This clinical trial studies the following conditions: Endoscopy, UGI Bleeding, Ulcer or Variceal Hemorrhage, Stigmata of Recent Hemorrhage, Randomized Controlled Trials.
What interventions are being tested in trial NCT00732212?
The interventions under investigation include: Doppler endoscopic ultrasound probe for blood flow detection (DEVICE), Standard endoscopic hemostasis (OTHER).
Who is sponsoring clinical trial NCT00732212?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00732212 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
COMPLETED · NA
-
Is End Tidal CO2 Level Elevation During Upper Endoscopy With CO2 Gas Insufflation Physiologically Significant
COMPLETED · NA
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
RECRUITING · Phase 3
-
A Safety Study of 3 Different Bowel Cleansing Preparations
COMPLETED · Phase 3
-
MANTIS Endoscopic Clipping Study
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01524211 · 235 participants · NA
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
- NCT05316155 · 235 participants · Phase 1
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
- NCT05353569 · 235 participants · NA
Coherent Optical Detection of Middle Ear Disease
- NCT05390918 · 235 participants · NA
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI